| Patient | Fyodor Dostoevsky |
|---|---|
| Date of birth | 1982-11-11 |
| Identifiers | MRN HR-NI018-SYN; SSN (made up) 000-18-3907 |
| Document date | 2026-10-06 |
| Author | Agnes Lindahl, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Eight-month review after a breakthrough seizure and a gambling lapse while traveling. [S]
Mr. Dostoevsky returns three weeks after coming home from two months abroad. About four weeks ago, in a spa town he had not planned to visit, he went into a casino and played roulette on four evenings over one week, losing about two months of his income; he borrowed money to come home. On the second of those nights he stayed at the tables until morning and missed his evening lamotrigine dose, then missed it again the next evening. The following morning he had a generalized tonic-clonic seizure in his hotel room, witnessed by a member of staff, lasting about two minutes; he bit his tongue and was confused for some hours. He was checked in a local emergency department and released the same day; he brought the discharge letter, which records a normal examination and no injury. He has taken every dose since and has had no further seizure. He did not tell the clinic until today, because he felt ashamed. He had arranged no telehealth therapy sessions before leaving and had none while away. He has not gambled since he came home three weeks ago. He feels ashamed and worried about the new debt but says he has no thoughts of suicide and wants to get back on track. [S]
| Element | Detail |
|---|---|
| Seizure | One generalized seizure about four weeks ago, after a night awake at the tables and two missed doses |
| Gambling | Roulette on four evenings abroad; large loss; none for three weeks |
| Therapy | No sessions during the two months away |
| Mood | PHQ-9 9, GAD-7 8; no thoughts of suicide |
| System | Result | Finding |
|---|---|---|
| Neurological | Positive | One seizure about four weeks ago; none since; no dizziness or double vision |
| Musculoskeletal | Positive | Right shoulder sore for a week after the seizure, now easing |
| Psychiatric | Positive | Shame, worry about debt, and poor sleep the first week home; no thoughts of suicide or self-harm |
| Integumentary | Negative | No rash |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Lamotrigine 25 mg tablets, slow titration: 25 mg once daily for weeks 1 and 2, 50 mg once daily for weeks 3 and 4, 50 mg twice daily for week 5, and 75 mg twice daily for week 6 | 25 mg once daily, increased every two weeks and then weekly as written, to 75 mg twice daily in week 6 | Oral route | 2026-03-03 to 2026-04-13 | completed | S |
| Lamotrigine 100 mg tablet, one tablet twice daily | 100 mg twice daily (200 mg a day), 30-day supply at a time | Oral route | 2026-04-14 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-10-06 | Body height | 170 | cm | S |
| 2026-10-06 | Body weight | 68 | kg | S |
| 2026-10-06 | Body mass index (BMI) [Ratio] | 23.5 | kg/m2 | S |
| 2026-10-06 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2026-10-06 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-10-06 | Heart rate | 78 | /min | S |
| 2026-10-06 | Respiratory rate | 14 | /min | S |
| 2026-10-06 | Body temperature | 36.7 | Cel | S |
| 2026-10-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-10-06 | lamoTRIgine [Mass/volume] in Serum or Plasma | 5.9 | ug/mL | 2.5-15 ug/mL | Normal | S |
| 2026-10-06 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 9 | {score} | S | ||
| 2026-10-06 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 8 | {score} | S |
Vital signs recorded on 2026-10-06; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Tired and subdued; weight 68.0 kg; blood pressure 126/80, heart rate 78 |
| Mouth | Healed scar on the right side of the tongue |
| Musculoskeletal | Full range of motion of the right shoulder with mild discomfort at the end of range; no deformity |
| Neurological | No nystagmus, ataxia, or focal deficit |
| Psychiatric | Low but reactive mood; organized; no suicidal thinking; good insight and engaged in planning |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Epilepsy of unknown type with recurrent generalized tonic-clonic seizures of unknown onset, untreated for many years; etiology unknown | active | confirmed | G40.909 | S — Synthetic modern coding of his documented epilepsy. The seizure type is left as unknown onset under the ILAE classification, because the retrospective classifications are disputed; no focal or generalized syndrome is coded. |
| Gambling disorder (roulette, in person and online), moderate, with debts | active | confirmed | F63.0 | S — Synthetic modern coding of his documented compulsive roulette gambling. |
| Acute viral gastroenteritis with vomiting and two missed lamotrigine doses, without dehydration needing intravenous fluids; resolved | resolved | confirmed | A08.4 | S — Synthetic intercurrent illness at an unscheduled visit, chosen to teach missed antiseizure doses during vomiting; it does not echo a documented illness. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Seizure frequency, seizure diary, and seizure description | Every visit | Completed today | One provoked generalized seizure about four weeks ago; none since |
| Referral | Neurology review | In January, or sooner after a breakthrough seizure | Completed today | Dr. Halvorsen reviewed by message today: no dose change; January review kept |
| Self-management | Report of a breakthrough seizure to the clinic within a day | After any seizure | Deferred | Not reported until today, about four weeks later. The emergency department examination was normal and no further seizure followed, so no harm is evident. Corrective action: the seizure action plan now says to call or message within a day, and the clinic will check in by message during future trips |
| Medication safety | Adherence and missed doses | Every visit | Completed today | Two evening doses missed abroad; every dose taken since |
| Laboratory | Lamotrigine trough level | Once at steady state as a reference, then with breakthrough seizures, suspected nonadherence, or interacting medicines | Completed today | 5.9 ug/mL trough after the breakthrough seizure, close to his reference level of 6.2 |
| Medication safety | Antiseizure medicine adverse effects (dizziness, double vision, unsteadiness, sleep, mood) | Every visit | Completed today | None |
| Self-management | Trigger review: sleep loss, alcohol, overwork, missed doses | Every visit | Completed today | Sleep loss at the tables and missed doses; gambling and seizure triggers overlap |
| Self-management | Seizure safety and driving counseling | At diagnosis and every visit | Completed today | Not driving; precautions reviewed again |
| Self-management | SUDEP discussion | At diagnosis and when seizure control changes | Completed today | Revisited because control changed: missed doses and nights alone raise the risk; adherence and sleep are the main protections |
| Medication safety | Rescue medicine for prolonged seizures or clusters | If seizures are prolonged or come in clusters | Not indicated | Single brief seizure |
| Survey | Depression screen (PHQ-9) | At intake, then every two to four months while symptoms are present | Completed today | PHQ-9 9, item 9 scored 0; up from 5 after the lapse |
| Survey | Anxiety screen (GAD-7) | At intake and with any change in mood | Completed today | GAD-7 8 |
| Survey | Suicide-risk review and safety plan, with the 988 Suicide & Crisis Lifeline | Every visit (gambling disorder and antiseizure-medicine labeling) | Completed today | Reassessed after a large loss: no thoughts of suicide, intent, or plan; safety plan updated; friend checking in nightly this week |
| Survey | Gambling since the last visit: days, money lost, and urges (G-SAS for the past week) | Every visit | Completed today | Gambled on four evenings abroad with a large loss; none for three weeks; G-SAS 22 for the past week, from strong urges and distress |
| Self-management | Cognitive behavioral therapy for gambling disorder | Weekly sessions for at least 8 to 12 weeks, then as needed | Deferred | No sessions for two months: the telehealth sessions planned at the last visit were never booked. Harm: the lapse occurred without support. Corrective action: weekly sessions resume this week, and therapy for any future trip is booked before departure |
| Self-management | Self-exclusion from casinos and online gambling | At the start of treatment; renew and extend after any lapse | Completed today | Renewed at home and extended to the major international online operators he uses |
| Self-management | Financial safeguards (bank gambling block, co-signer for large withdrawals, limited cash) | At the start of treatment, and after any lapse | Completed today | Bank block kept; his credit card is now held by the co-signing friend while he travels |
| Referral | Peer support (Gamblers Anonymous) | Offered at the start of treatment and after any lapse | Completed today | Back to weekly Gamblers Anonymous |
| Referral | Debt counseling | Again after any new debt | Ordered | Appointment to add the new debt to the plan |
| Medication safety | Medicine for gambling disorder (opioid antagonist) | Considered if psychological treatment alone is not enough | Not indicated | Discussed; he prefers to intensify therapy first; reconsider if gambling continues |
Goal progress:
Guideline basis: Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2015); Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy (2018); Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors (2017); Psychological therapies for pathological and problem gambling (2012); Gambling disorder (2019); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)
Follow-up: Adult preventive visit in two weeks. Nurse telephone check in one week. Neurology review in January. Next scheduled visit 2026-10-20: adult preventive visit. [S]